India · Delayed Price · Currency is INR MPS Pharmaa Statistics
Total Valuation
MPS Pharmaa has a market cap or net worth of INR 32.11 million. The enterprise value is 107.12 million.
| Market Cap | 32.11M |
| Enterprise Value | 107.12M |
Important Dates
The last earnings date was Monday, February 2, 2026.
| Earnings Date | Feb 2, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MPS Pharmaa has 19.11 million shares outstanding. The number of shares has decreased by -3.21% in one year.
| Current Share Class | 19.11M |
| Shares Outstanding | 19.11M |
| Shares Change (YoY) | -3.21% |
| Shares Change (QoQ) | +0.05% |
| Owned by Insiders (%) | 21.72% |
| Owned by Institutions (%) | 1.06% |
| Float | 5.71M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 157,388.00 |
| PB Ratio | 4.97 |
| P/TBV Ratio | 4.97 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -11.39 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 11.63 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -864.24 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -11.25% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 1.03% |
| Revenue Per Employee | 11 |
| Profits Per Employee | -522,333 |
| Employee Count | 18 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, MPS Pharmaa has paid 226,462 in taxes.
| Income Tax | 226,462 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -59.90% in the last 52 weeks. The beta is -0.16, so MPS Pharmaa's price volatility has been lower than the market average.
| Beta (5Y) | -0.16 |
| 52-Week Price Change | -59.90% |
| 50-Day Moving Average | 2.54 |
| 200-Day Moving Average | 2.47 |
| Relative Strength Index (RSI) | 23.98 |
| Average Volume (20 Days) | 1,843 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, MPS Pharmaa had revenue of INR 204 and -9.40 million in losses. Loss per share was -0.50.
| Revenue | 204 |
| Gross Profit | -178,807 |
| Operating Income | -9.16M |
| Pretax Income | -9.18M |
| Net Income | -9.40M |
| EBITDA | -7.69M |
| EBIT | -9.16M |
| Loss Per Share | -0.50 |
Balance Sheet
The company has 43,000 in cash and 75.06 million in debt, with a net cash position of -75.01 million or -3.92 per share.
| Cash & Cash Equivalents | 43,000 |
| Total Debt | 75.06M |
| Net Cash | -75.01M |
| Net Cash Per Share | -3.92 |
| Equity (Book Value) | 6.45M |
| Book Value Per Share | 0.35 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | -4,490,661.76% |
| Pretax Margin | -4,497,810.29% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
MPS Pharmaa does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 3.21% |
| Shareholder Yield | 3.21% |
| Earnings Yield | -29.28% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |